Bedaquiline is a diarylquinoline antimycobacterial agent indicated for the treatment of pulmonary multidrug-resistant tuberculosis. It functions through a unique mechanism that involves inhibiting the… Read more




















Bedaquiline is a diarylquinoline antimycobacterial agent indicated for the treatment of pulmonary multidrug-resistant tuberculosis. It functions through a unique mechanism that involves inhibiting the mycobacterial ATP synthase enzyme, thereby disrupting the energy production essential for the survival of Mycobacterium tuberculosis. Within this category, a comprehensive range of reference standards, including the active pharmaceutical ingredient, is available to support rigorous analytical testing and quality control. Laboratories utilize these high-quality materials, such as related impurities, degradation products, and metabolites like desmethyl and desmethoxy derivatives, for critical impurity profiling and method validation. Furthermore, the inclusion of stable isotope labelled compounds provides essential internal standards for quantitative mass spectrometry-based assays. These materials are instrumental in ensuring the accuracy of analytical procedures and verifying regulatory compliance throughout the development and manufacturing lifecycle of pharmaceutical products.